Effects of KRN4884, a novel pyridinecarboxamidine type K(ATP) channel opener, on serum triglyceride levels in rats

British Journal of Pharmacology

Volumn 120, Issue 8, 1997, Pages 1471-1476

  Yokoyama, Takashi ^a   Izumi, Hideakira ^a   Endoh, Megumi ^a   Izawa, Toshio ^a   Ogawa, Nobuyuki ^a   Okada, Yuji ^a  

^a KIRIN BREWERY CO LTD   (Japan)

Author keywords

K(ATP) channel opener; KRN4884; Lipoprotein lipase; Triglyceride

Indexed keywords

5 AMINO N [2 (2 CHLOROPHENYL)ETHYL] N' CYANO 3 PYRIDINECARBOXAMIDINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM); AMIDINE; CHOLESTEROL; CHYLOMICRON; CLOFIBRATE; FATTY ACID; LIPOPROTEIN LIPASE; PHOSPHOLIPID; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; TRIACYLGLYCEROL; TYLOXAPOL; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; LIPID METABOLISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030972447     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701077     Document Type: Article

References (35)

1. ADAMS, L.L., WEBB, W.W. & FALLON, H. (1971). Inhibition of hepatic triglyceride formation by clofibrate. J. Clin. Invest., 50, 2339-2346.
2. ALEGRET, M., FERRANDO, R., VAZQUEZ, M., ADZET, T., MERLOS M. & LAGUNA, J.C. (1994). Relationship between plasma lipids and palmitoyl-CoA hydrolase and synthetase activities with peroxisomal proliferation in rats treated with fibrates. Br. J. Pharmacol., 112, 551-556.
3. ARNOLD, A., MCAULIFF, J.P. & BEYLER, A.L. (1979). Metabolic effects of a new hypolpidemic agent, ciprofibrate. J. Pharmac. Sci., 68, 1557-1558.
4. ASHCROFT, S.J.H. & ASHCROFT, F.M. (1990). Properties and function of ATP-sensitive K-channels. Cell Signaling 2, 197-214.
5. AUSTIN, M.A. (1991). Plasma triglyceride and coronary heart disease. Arterioscler. Thromb., 11, 2-14.
6. CAPURSO, A. (1991). Drugs affecting triglycerides. Cardiology 78, 218-225.
7. FRENKEL, B., MAYOREK, N., HERTZ, R. & BAR-TANA, J. (1988). The hypochylomicronemic effect of β,β′-methyl-substituted hexadecanedioic acid (MEDICA 16) is mediated by a decrease in apolipoprotein C-III. J. Biol. Chem., 263, 8491-8497.
8. FUJIOKA, S., MATSUZAWA, Y., TOKUNAGA, K. & TARUI, S. (1987). Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism, 36, 54-59.
9. GALAN, X., LLOBERA, M. & RAMIREZ, I. (1994). Lipoprotein lipase and hepatic lipase in Wistar and Sprague-Dawley rat tissues. Differences in the effects of gender and fasting. Lipids, 29, 333-336.
10. GRUNDY, S.M. & VEGA, G.L. (1987). Fibric acids: effects on lipids and lipoprotein metabolism. Am. J. Med., 83 (suppl 5B), 9-20.
11. HATCH, F.T. & LEE, R.S. (1968). Practical methods for plasma lipoprotein analysis. Adv. Lipid Res., 6, 1-68.
12. HIRANO, T., KOMURO, F., FURUKAWA, S., NAGANO, S. & TAKAHASHI, T. (1990). Effect of pravastatin sodium, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on very-low-density lipoprotein composition and kinetics in hyperlipidemia associated with experimental nephrosis. Metabolism, 39, 605-609.
13. IZUMI, H., JINNO, Y., KANETA, S., TANAKA, Y., OKADA, Y., IZAWA, T. & OGAWA, N. (1995). Effects of KRN4884, a novel K channel opener, on the cardiovascular system in anesthetized dogs: a comparison with levcromakalim, nilvadipine, and nifedipine. J. Cardiovasc. Pharmacol., 26, 189-197.
14. KAPLAN, N.M. (1989). The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med., 149, 1514-1520.
15. KASAI, H., OKADA, Y., KASHIWABARA, T., OGAWA, N., IZAWA, T. & FUKUSHIMA, H. (1995). Differences between the effects of KRN4884, a novel potassium channel opener, and nifedipine on phenylephrine-induced responses in rat aorta. Jpn. J. Pharmacol., 67 (Suppl I), 176p.
16. KASHIWABARA, T., OKAWARA, H., NAKAJIMA, T., NAKAJIMA, S., MURAKAMI, I., YONEZAWA, Y., OKADA, Y., OGAWA, N., IZAWA, T. & FUKUSHIMA, H. (1994). Vasodilating and antihypertensive properties of KRN4884, a novel long lasting potassium channel opener. Can. J. Physiol. Pharmacol., 72 (Suppl 1), 126.
17. KASIM, S.E., LEBOEUF, R.C., KHILNANI, S., TALLAPAKA, L., DAYANANDA, D. & JEN, C. (1992). Mechanism of triglyceride-lowering effect of an HMG-CoA reductase inhibitor in a hypertriglyceridemic animal model, the Zucker obese rat. J. Lipid Res., 33, 1-7.
18. MARAGOUDAKIS, M.E., HANKIN, H. & WASVARY, J.M. (1972). On the mode of action of lipid-lowering agents. VII. In vivo inhibition and reversible binding of hepatic acetyl coenzyme A carboxylase by hypolipidemic drugs. J. Biol. Chem., 247, 342-347.
19. MATZNO, S., GOHDA, M., EDA, M., EBISU, H., UNO, S., ISHIDA, N., NAKAMURA, N. & YAMANOUCHI, K. (1994). A possible mechanism of action of a new potassium channel opener, AL0671, on lipid metabolism in obese Zucker rats. J. Pharmacol. Exp. Ther., 271, 1666-1671.
20. NAKAJIMA, T., NAKAJIMA, S., IZAWA, T., KASHIWABARA, T. & MUNEZUKA, Y. (1994). Cyanoamidines. II. Synthesis and pharmacological activity of N-arylalkyl-N′-cyano-3-pyridinecarboxamidine. Chem. Pharm. Bull., 42, 2483-2490.
21. NILSSON-EHLE, P., GARFINKEL, A.S. & SCHOTZ, M.C. (1980). Lipolytic enzyme and plasma lipoprotein metabolism. Ann. Rev. Biochem., 49, 667-693.
22. NILSSON-EHLE, P. & SCHOTZ, M.C. (1976). A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J. Lipid Res., 17, 536-541.
23. ODONKOR, J.M. & ROGERS, M.P. (1984). Effects of ethyl-CPIB (clofibrate) on tissue lipoprotein lipase and plasma post-heparin lipolytic activity in rats. Biochem. Pharmacol., 33, 1337-1341.
24. OLIVIER P., PLANCKE, M.O., THERET, N., MARZIN, D., CLAVEY, V. & FRUCHART, J.C. (1988). Effects of fenofibrate on lipid metabolism and fatty acid distribution in Zucker rats. Atherosclerosis, 74, 15-21.
25. POYSER, R.H. & HAMILTON, T.C. (1994). Potassium channel modulators: current situation and future expectations. Drugs of the Future, 19, 39-47.
26. + channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats. J. Pharmacol. Exp. Ther., 258, 216-222.
27. REAVEN, G.M. (1988). Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37, 1595-1607.
28. REAVEN, G.M., RISSER, T.R., CHEN, Y-D.I. & REAVEN, E.P. (1979). Characterization of a model of dietary-induced hypertriglyceridemia in young, nonobese rats. J. Lipid Res., 20, 371-378.
29. ROCKHOLD, F.W., GOLDENBERG, M.R. & THOMPSON, W.L. (1989). Beneficial effects of pinacidil on blood lipids: comparison with prazosin and placebo in patients with hypertension. J. Lab. Clin. Med., 114, 646-654.
30. SATO, A., WATANABE, K., FUKUZUMI, H., HASE, K., ISHIDA, F. & KAMEI, T. (1991). Effect of simvastatin (MK-733) on plasma triacylglycerol levels in rats. Biochem. Pharmacol., 41, 1163-1172.
31. STEINER, G., HAYNES, F.J., YOSHINO, G. & VRANIC, M. (1984). Hyperinsulinemia and in vivo very-low-density lipoprotein-triglyceride kinetics. Am. J. Physiol., 246, E187-E192.
32. STRANDBERG, T.E., KUUSI, T., TILVIS, R.S. & MIETTINEN, T.A. (1983). Clofibrate decreases jejunal cholesterol synthesis and activity of postheparin plasma lipoprotein lipase in the rat. Pharmacology, 26, 290-296.
33. SUGO, I., YOSHIDA, S., SATOH, K., KAMEI, K., IMAGAWA, J., AKIMA, M., NABATA, H., HAYASAKA, A. & CHIBA, N. (1994). Effects of KC-515, a new K channel opener, in several hypertensive and hyperlipidemia models of rats. Jpn. J. Pharmacol., 64, 336p.
34. TATSUMI, K., INOUE, Y., SHIMA, A., IWASAKI, K., KAWAMURA, M. & MURASE, T. (1993). The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherosclerosis in the coronary arteries of rats with experimental atherosclerosis. J. Clin. Invest., 92, 411-417.
35. VAINIO, H., LINNAINMAA, K., KÄHÖNEN, M., NICKELS, J., HIETANEN, E., MARNIEMI, J. & PELTONEN, P. (1983). Hypolipidemia and peroxisome proliferation induced by phenoxyacetic acid herbicides in rats. Biochem. Pharmacol., 32, 2775-2779.